You are here

AltruBio

AltruBio lands up to $225M after shift to immune drug research

BioPharma Dive

Tue, 05/21/24 - 11:18 am

ulcerative colitis

Three Influential Women in Biopharma Explain How to Break the Executive Barrier

BioSpace

Thu, 11/17/22 - 11:30 pm

women executives

X4 Pharmaceuticals

Fresh Biopharmas Join the Race to Cutting-Edge Treatments and Testing

BioSpace

Fri, 04/16/21 - 09:44 am

Tectonic Therapeutics

Alchemab Therapeutics

New name, new board, new focus: AltruBio relaunches with $63M series A

Fierce Biotech

Thu, 04/15/21 - 10:04 am